Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus - Wikidata - awgldk - TriplyDB

Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus

Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus

http://www.wikidata.org/entity/Q35497147

about

Diagnostic approaches for diabetic cardiomyopathy.Subclinical Alterations of Cardiac Mechanics Present Early in the Course of Pediatric Type 1 Diabetes Mellitus: A Prospective Blinded Speckle Tracking Stress Echocardiography Study.Prevalence of QT prolongation and associated LVEF changes in diabetic patients over a four-year retrospective time period The influence of real-time blood glucose levels on left ventricular myocardial strain and strain rate in pediatric patients with type 1 diabetes mellitus - a speckle tracking echocardiography study.Silent diabetic cardiomyopathy in everyday practice: a clinical and echocardiographic study Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes Impact of obesity and epicardial fat on early left atrial dysfunction assessed by cardiac MRI strain analysis.Subclinical left ventricular diastolic dysfunction and incident type 2 diabetes risk: the Korean Genome and Epidemiology Study.Update on Echocardiographic Assessment in Diabetes Mellitus.Changes in proteinuria and the risk of myocardial infarction in people with diabetes or pre-diabetes: a prospective cohort study.Impact of overweight on left ventricular function in type 2 diabetes mellitus.Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes.Potential impact of SGLT2 inhibitors on left ventricular diastolic function in patients with diabetes mellitus.Subclinical left ventricular systolic and diastolic dysfunction in type 1 diabetic children and adolescents with good metabolic control.Presence of micro- and macroalbuminuria and the association with cardiac mechanics in patients with type 2 diabetes.Impact of left ventricular longitudinal functional mechanics on the progression of diastolic function in diabetes mellitus.Future Perspectives for Management of Stage A Heart Failure

P2860

Q30362092-D9BA7563-2EE5-4E65-9D36-AA73E466031D Q30391941-2382F405-2C9F-4404-9C45-ADB2A50BD40D Q33806055-0C7E03DA-E3D5-4B34-BE0B-92020F0BE108 Q35874729-4EC7FB8D-6120-4FC4-823C-F17A2391D14A Q36205861-2285C867-1351-4E89-91E2-DBA0A8AC0C34 Q36537308-BF3ED84C-8C1D-48BF-A800-613670435706 Q37171547-971C09AC-4D6F-4248-87CB-FFD8838BB419 Q37278695-7949F376-523C-427C-83FD-256F811496C8 Q37526616-0996DEFD-9231-4DA0-BBFF-C057C53FF5A9 Q37700844-FCCF1AAD-1381-4A48-9F03-5C0652A0C6ED Q38904542-3087E3AD-8615-423F-92CE-DD1A2B4992D6 Q40083560-E6C11AD7-462A-4C23-B279-2B638047D73D Q47146474-C8844D42-0F13-4E70-9F1F-84464F4D0A4C Q47223795-4B41CD35-7A7A-4233-B47B-E012EB496CDF Q47734427-028CF7A0-2CF5-418D-BC7A-8AB48707A5DB Q48179950-510F7305-6968-47E9-A64B-3D6421FF9927 Q48524715-C9C8F6FD-53F3-4AE6-AFE5-D422B156D007 Q50568386-C409F3F6-AA4A-4B7D-B64D-F548C04FB747 Q57178331-969DC535-0F15-4661-80D2-A88059E1D069

P2860

Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus

http://www.wikidata.org/entity/Q35497147

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Clinical features of subclinic ...... atients with diabetes mellitus

@ast

Clinical features of subclinic ...... atients with diabetes mellitus

@en

type

label

Clinical features of subclinic ...... atients with diabetes mellitus

@ast

Clinical features of subclinic ...... atients with diabetes mellitus

@en

prefLabel

Clinical features of subclinic ...... atients with diabetes mellitus

@ast

Clinical features of subclinic ...... atients with diabetes mellitus

@en

P1433

Q35497147-E59AAEBF-F033-47DA-A195-4936C65B2135

P1476

Q35497147-A9F6BD23-BB02-4890-9BF0-DF5B3A86E10F

P2093

Q35497147-1DA4F761-E04F-499C-9744-AAF09449FB12

Q35497147-59544C18-4F3F-4EB3-82E0-3E3DFE4CD483

Q35497147-751A3A7C-5B25-47E0-8C5D-D236D18829F2

Q35497147-89A0CE90-07B8-40BC-B32E-2B1E2F2069A2

Q35497147-A9A353F6-8F7B-42AB-84B2-678B5009283A

Q35497147-B8187DCC-B0D3-4557-B7D9-4C55888E3F22

Q35497147-C45738FC-5DFB-4923-96D1-9764A96FEC74

Q35497147-CE74BE0C-1086-4A0F-8890-36EE7B216060

Q35497147-D2392C35-62CB-490E-BC86-5C90CB55C8F7

Q35497147-E192542E-F95B-48CE-89D5-6327A9A96EDF

P2860

Q35497147-017493D5-2FFD-457A-A63B-84CEAFA13C9F

Q35497147-071EACA5-D36C-4BA3-BE2B-F6515D1D9500

Q35497147-0AE2D4C7-99EC-4835-9186-15F4F680D5B6

Q35497147-11E12EF2-920C-41F1-9983-0E7E6DA963F8

Q35497147-16AA73EB-828C-4DBB-99CF-D836505E2BF5

Q35497147-19ACCD13-747C-4DD8-A40A-5CCE3D3C16CC

Q35497147-20D19E82-21E9-407A-83C6-8457F77ADA92

Q35497147-2128C9AF-CB24-47C4-BEC3-90A6619E6419

Q35497147-29550ADC-2A6C-4B2A-B466-E9DDCE05E6A3

Q35497147-3607D8FC-2D6B-4670-B378-ACBE6084CBF1

P2888

Q35497147-85481B0E-E91C-46C6-962F-38BC3DD27BF4

P304

Q35497147-5D43067C-86C1-447E-A426-2659F8B46D4D

P31

Q35497147-9F93A251-EEA6-492B-BA23-8803D1970D3C

P356

Q35497147-F9D39E45-62E5-48F6-8A52-806114270D38

P407

Q35497147-6459022D-52A3-4E18-BA0D-7422011E4FC6

P478

Q35497147-08082AF9-05C2-4672-9AB0-49E418C17A6F

P577

Q35497147-BA375656-AED8-4C99-B77F-880C91955943

P5875

Q35497147-411BCECD-E040-4903-8A2A-5A057D4065DB

P6179

Q35497147-245869F2-3CD5-4004-8D0D-CBE135ED8314

P698

Q35497147-77A42BFB-06FF-44A3-9036-EED6A4FAB97C

P921

Q35497147-C4F813A0-1FF6-4EFC-AE71-1E0EC5F79FB0

P932

Q35497147-BE85D2B1-44E5-4668-9615-887D2A5CCE5B

P356

S12933-015-0201-8

P1433

Cardiovascular Diabetology

P1476

Clinical features of subclinic ...... atients with diabetes mellitus

@en

P2093

Hidekazu Tanaka

http://www.w3.org/2001/XMLSchema#string

Hiromi Toki

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Sano

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Shimoura

http://www.w3.org/2001/XMLSchema#string

Junichi Ooka

http://www.w3.org/2001/XMLSchema#string

Keiko Ryo

http://www.w3.org/2001/XMLSchema#string

Ken-ichi Hirata

http://www.w3.org/2001/XMLSchema#string

Kensuke Matsumoto

http://www.w3.org/2001/XMLSchema#string

Takuma Sawa

http://www.w3.org/2001/XMLSchema#string

Wataru Ogawa

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy.

Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.

Insulin resistance and subclinical abnormalities of global and regional left ventricular function in patients with aortic valve sclerosis.

Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

P2888

s12933-015-0201-8

P304

37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-015-0201-8

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275101648

http://www.w3.org/2001/XMLSchema#string

P6179

1036485045

http://www.w3.org/2001/XMLSchema#string

P698

25889250

http://www.w3.org/2001/XMLSchema#string

P921

P932

4404084

http://www.w3.org/2001/XMLSchema#string